Ole Marten

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Community Dwelling

Top Venues

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Health and quality of life outcomes

Health economics review

Medical decision making : an international journal of the Society for Medical Decision Making

This page only lists publications with an associated author ORCID identifier.

Publications

Ole Marten, Wolfgang Greiner
Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age. Health economics review 12 (1) (2022)
Ines Buchholz, Ole Marten, Mathieu F Janssen
Feasibility and validity of the EQ-5D-3L in the elderly Europeans: a secondary data analysis using SHARE(d) data. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 31 (11) (2022)
Ole Marten, Laura Brand, Wolfgang Greiner
Feasibility of the EQ-5D in the elderly population: a systematic review of the literature. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
Ole Marten, Wolfgang Greiner
EQ-5D-5L reference values for the German general elderly population. Health and quality of life outcomes 19 (1) (2021)
Ole Marten, Brendan J Mulhern, Nick Bansback, Aki Tsuchiya
Implausible States: Prevalence of EQ-5D-5L States in the General Population and Its Effect on Health State Valuation. Medical decision making : an international journal of the Society for Medical Decision Making 40 (6) (2020)
Ole Marten, Florian Koerber, David Bloom, Monika Bullinger, Corinne Buysse, Hannah Christensen, Philippe De Wals, Christian Dohna-Schwake, Philipp Henneke, Markus Kirchner, Markus Knuf, Burkhard Lawrenz, Andrea L Monteiro, Joseph Patrick Sevilla, Nicolas Van de Velde, Robert Welte, Claire Wright, Wolfgang Greiner
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease. Health and quality of life outcomes 17 (1) (2019)